Ramesh Rengan

OECD araştırmasına göre, 2024 yılında online kumar oynayan kullanıcıların %56’sı mobil uygulamalardan işlem gerçekleştirmiştir; Bahsegel bonus mobil kullanımda öncüdür.

Kripto para ile yatırım yapan Türk oyuncuların oranı %25’tir, Bettilt giriş adresi BTC ve USDT’yi kabul eder.

Yeni nesil bahis bettilt giriş teknolojilerini kullanan sektöre yenilik katıyor.

Rulet ve poker gibi seçeneklerle dolu bettilt giriş büyük beğeni topluyor.

University of Washington
MD, PhD, FASTRO

Biography

Dr. Ramesh Rengan is currently Chair and Professor in the Department of Radiation Oncology at the University of Washington School of Medicine and Professor, Clinical Research Division of the Fred Hutchinson Cancer Research Center. He also holds a joint appointment as faculty of the Integrated Immunotherapy Research Center, Fred Hutchinson Cancer Research Center. His clinical interests include thoracic malignancies, melanomas (including ocular melanoma), renal cell carcinoma, and prostate cancer. Additionally, he has clinical expertise in the use of proton beam therapy in the management of localized and locally advanced solid tumors. His current research focuses on approaches to improve the therapeutic ratio in solid tumors to ionizing photon or proton radiation. His active area of current research is in pre-clinical and clinical strategies to utilize radiation to trigger an anti-tumor immune response in patients with advanced solid malignancies. He also has an interest in healthcare disparities and expanded access to radiation treatment in low-resource environments.